New Zealand markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
183.52-3.57 (-1.91%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
6,683,766
6,205,683
4,162,821
3,047,597
2,488,652
Cost of revenue
809,584
736,300
547,758
409,539
275,119
Gross profit
5,874,182
5,469,383
3,615,063
2,638,058
2,213,533
Operating expenses
Research development
2,823,144
1,829,537
1,754,540
1,416,476
1,324,625
Selling general and administrative
783,140
770,456
658,498
557,616
496,079
Total operating expenses
3,606,284
2,599,993
2,413,038
1,974,092
1,820,704
Operating income or loss
2,267,898
2,869,390
1,202,025
663,966
392,829
Interest expense
61,300
58,151
58,502
34,119
57,550
Total other income/expenses net
196,583
283,320
187,718
-29,606
-350,968
Income before tax
2,411,199
3,116,798
1,394,919
600,241
-15,689
Income tax expense
419,513
405,151
218,109
-1,486,862
-107,324
Income from continuing operations
1,991,686
2,711,647
1,176,810
2,087,103
91,635
Net income
1,991,686
2,711,647
1,176,810
2,096,896
263,484
Net income available to common shareholders
1,991,686
2,711,647
1,176,810
2,096,395
263,191
Basic EPS
-
10.44
4.58
8.24
1.06
Diluted EPS
-
10.29
4.51
8.09
1.04
Basic average shares
-
259,841
256,728
254,292
248,858
Diluted average shares
-
263,396
260,673
259,185
253,225
EBITDA
-
3,284,464
1,560,362
706,780
103,258